The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for ...

The European Commission has fined Israeli drugmaker Teva (TEVA) $500M for disparaging a rival product to its blockbuster multiple sclerosis drug Copaxone. Read more here.

The EU Commission said Teva’s actions may have prevented significant savings by countries across Europe, with other versions of the drug possibly 80% cheaper than Copaxone.

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for ...

Last year, Teva was ordered to pay $225 million to settle price fixing charges in the U.S. related to sales of a cholesterol-lowering drug. The U.S. Justice Department said the agreement also ...

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for ...

BRUSSELS (AP) — The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its ...

FILE - Israeli flag flies outside Teva Pharmaceutical facility building in Neot Hovav, Israel, on Dec. 14, 2017. (AP Photo/Tsafrir Abayov, File) BRUSSELS (AP) — The European Commission said Thursday ...